Prevalence and progression of cardiovascular calcifications in peritoneal dialysis patients: A prospective study

Bone

Volumn 51, Issue 3, 2012, Pages 332-337

  Gallieni, Maurizio ^a   Caputo, Flavia ^b   Filippini, Armando ^c   Gabella, Paolo ^d   Giannattasio, Michele ^e   Stingone, Antonio ^f,i   Farina, Marco ^g   Amato, Marcello ^h   Avella, Ferdinando ⁱ   Pietà, Ospedale S Maria della ⁱ   Bertoli, Massimo ^j   Bocci, Carlo ^k   Borgatti, Pierpaolo ⁱ   Nuova, Arcispedale S Maria ⁱ   Buongiorno, Erasmo ^l   Cavatorta, Fosco ^l,m   Cabiddu, Gianfranca ⁿ   Brotzu, Ospedale G ⁿ   Coratelli, Cagliari Pasquale ⁿ   Costanzo, Riccardo ^o   Daidone, Giuseppe ^p   D'Angelo, Angela ^q   Grotta, Franco Della ⁱ   Vecchi, Amedeo De ^r   Ferrari, Giacomo ^s   Gaggiotti, Enzo ⁱ   Scala, Ospedale S Maria della ⁱ   Fanciulli, Emilia ^t   Fusaroli, Maurizio ⁱ   Croci, Ospedale S Maria delle ⁱ   Rosa, Roberto La ⁱ   Angeli, Ospedale S Maria degli ⁱ   Malberti, Fabio ^u   Marinangeli, G Carlo ⁱ   Mauro, Matteo Maurizio ^v   Oliva, Barbara ^w   Orazi, Ersilia ⁱ   Predabissi, Ospedale ⁱ   Rapisarda, Francesco ^x   Rocca, Anna Rachele ^y   Ronco, Claudio ⁱ   Bortolo, Ospedale S ⁱ   Sacchetti, Antonio ^z   Sasdelli, Mauro ⁱ   Donato, Ospedale S ⁱ   Scanziani, Renzo ^aa   Sessa, Adalberto ^ab   Spinelli, Cosimo ⁱ   Spirito, Ospedale S ⁱ   Stefoni, Sergio ⁱ   Malpighi, Policlinico S Orsola ⁱ   Bernabeo, Ospedale G ⁱ   Viglino, Giusto ⁱ   Lazzaro, Ospedale S ⁱ   more..

^a SAN CARLO BORROMEO HOSPITAL   (Italy)

^b Nephrology and Dialysis Unit   (Italy)

^c Ospedale Casilino   (Italy)

^d MAURIZIANO HOSPITAL   (Italy)

^e Ospedale S Maria degli Angeli   (Italy)

^f Ospedale G Bernabeo   (Italy)

^g Azienda Ospedaliera di Lodi   (Italy)

^h MISERICORDIA E DOLCE HOSPITAL   (Italy)

ⁱ Ospedale Civile ^*

^j UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^k OSPEDALE CA FONCELLO   (Italy)

^l Ospedale Civile   (Italy)

^m Ospedale Maggiore   (Italy)

ⁿ POLICLINICO   (Italy)

^o MAGGIORE HOSPITAL   (Italy)

^p Osp Umberto I   (Italy)

^q UNIVERSITY OF PADOVA   (Italy)

^r FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^s UNIVERSITY OF GENOA   (Italy)

^t Azienda Ospedaliera Umberto I   (Italy)

^u CREMONA HOSPITAL   (Italy)

^v Ospedale di Desio   (Italy)

^w Ospedale Civile Di Vicenza   (Italy)

^x Presidio Ospedaliero Vittorio Emanuele   (Italy)

^y SAPIENZA UNIVERSITY OF ROME   (Italy)

^z Ospedale Civile Umberto I   (Italy)

^aa DESIO HOSPITAL   (Italy)

^ab Ospedale Civile   (Italy)

more..

Author keywords

Cardiovascular calcification; CKD MBD; Observational study; Peritoneal dialysis; Phosphorus; Survival

Indexed keywords

CALCIUM; PHOSPHORUS;

ADULT; AGED; ARTERY CALCIFICATION; ARTICLE; BLOOD CHEMISTRY; CALCIFICATION; CALCIUM BLOOD LEVEL; CARDIOVASCULAR CALCIFICATION; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VALVE CALCIFICATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PERITONEAL DIALYSIS; PHOSPHATE BLOOD LEVEL; PREVALENCE; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CALCINOSIS; CALCIUM; CARDIOMYOPATHIES; DEMOGRAPHY; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; ITALY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERITONEAL DIALYSIS; PHOSPHORUS; PREVALENCE; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84862633753     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.06.002     Document Type: Article

References (38)

1. Levin A., Bakris G.L., Molitch M., Smulders M., Tian J., Williams L.A., et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int Jan 2007, 71(1):31-38.
2. Adeney K.L., Siscovick D.S., Ix J.H., Seliger S.L., Shlipak M.G., Jenny N.S., et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol Feb 2009, 20(2):381-387.
3. Cannata-Andia J.B., Naves-Diaz M. Phosphorus and survival: key questions that need answers. J Am Soc Nephrol Feb 2009, 20(2):234-236.
4. United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis Jan 2009, 53(Suppl. 1):S1-374.
5. Ganesh S.K., Stack A.G., Levin N.W., Hulbert-Shearon T., Port F.K. Association of elevated serum PO(4), Ca×PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol Oct 2001, 12(10):2131-2138.
6. KDIGO KDIGO guidelines for identification and management of CKD-MBD. Kidney Int 2009, 76(Suppl. 113):S1-S130.
7. Kalantar-Zadeh K., Block G., Humphreys M.H., Kopple J.D. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int Mar 2003, 63(3):793-808.
8. Ammirati A.L., Dalboni M.A., Cendoroglo M., Draibe S.A., Santos R.D., Miname M., et al. The progression and impact of vascular calcification in peritoneal dialysis patients. Perit Dial Int May 2007, 27(3):340-346.
9. Vonesh E.F., Snyder J.J., Foley R.N., Collins A.J. Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us?. Kidney Int Suppl Nov 2006, 103:S3-S11.
10. Habib A.N., Baird B.C., Leypoldt J.K., Cheung A.K., Goldfarb-Rumyantzev A.S. The association of lipid levels with mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transplant Oct 2006, 21(10):2881-2892.
11. Kronenberg F., Lingenhel A., Neyer U., Lhotta K., Konig P., Auinger M., et al. Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients. Kidney Int Suppl May 2003, 84:S113-S116.
12. Nishizawa Y., Shoji T., Kakiya R., Tsujimoto Y., Tabata T., Ishimura E., et al. Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease. Kidney Int Suppl May 2003, 84:S117-S120.
13. Noordzij M., Korevaar J.C., Bos W.J., Boeschoten E.W., Dekker F.W., Bossuyt P.M., et al. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. Nephrol Dial Transplant Sep 2006, 21(9):2513-2520.
14. Weinhandl E.D., Foley R.N., Gilbertson D.T., Arneson T.J., Snyder J.J., Collins A.J. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol Mar 2010, 21(3):499-506.
15. Wang A.Y., Wang M., Woo J., Lam C.W., Li P.K., Lui S.F., et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol Jan 2003, 14(1):159-168.
16. Kimoto E., Shoji T., Emoto M., Miki T., Tabata T., Okuno Y., et al. Effect of diabetes on uremic dyslipidemia. J Atheroscler Thromb 2002, 9(6):305-313.
17. London G.M., Guerin A.P., Marchais S.J., Metivier F., Pannier B., Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant Sep 2003, 18(9):1731-1740.
18. Noordzij M., Cranenburg E.M., Engelsman L.F., Hermans M.M., Boeschoten E.W., Brandenburg V.M., et al. Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant May 2011, 26(5):1662-1669.
19. Stompor T., Pasowicz M., Sulowicz W., Dembinska-Kiec A., Tracz W. Trends in coronary artery calcification in peritoneal dialysis and transplant patients. Nephrol Dial Transplant Dec 2004, 19(12):3205-3206.
20. Blacher J., Guerin A.P., Pannier B., Marchais S.J., London G.M. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension Oct 2001, 38(4):938-942.
21. Savage D.D., Garrison R.J., Kannel W.B., Levy D., Anderson S.J., Stokes J., et al. The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study. Circulation Jan 1987, 75(1 Pt 2):I26-I33.
22. Foley R.N., Parfrey P.S. Cardiovascular disease and mortality in ESRD. J Nephrol Sep 1998, 11(5):239-245.
23. Li P.K., Chow K.M. The clinical and epidemiological aspects of vascular mortality in chronic peritoneal dialysis patients. Perit Dial Int Feb 2005, 25(Suppl. 3):S80-S83.
24. Mizobuchi M., Towler D., Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol Jul 2009, 20(7):1453-1464.
25. Moe S.M., Chen N.X. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res Sep 17 2004, 95(6):560-567.
26. Shlipak M.G., Katz R., Kestenbaum B., Siscovick D., Fried L., Newman A., et al. Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol Dec 2009, 20(12):2625-2630.
27. Wang A.Y., Woo J., Wang M., Sea M.M., Ip R., Li P.K., et al. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol Sep 2001, 12(9):1927-1936.
28. Wang A.Y., Woo J., Lam C.W., Wang M., Chan I.H., Gao P., et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant Aug 2005, 20(8):1676-1685.
29. Floege J. Calcium-containing phosphate binders in dialysis patients with cardiovascular calcifications: should we CARE-2 avoid them?. Nephrol Dial Transplant Oct 2008, 23(10):3050-3052.
30. Zoccali C., Benedetto F.A., Mallamaci F., Tripepi G., Giacone G., Stancanelli B., et al. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int Apr 2004, 65(4):1492-1498.
31. Hüting J., Alpert M.A. Progression of left ventricular hypertrophy in end-stage renal disease treated by continuous ambulatory peritoneal dialysis depends on hypertension and hypercirculation. Clin Cardiol Mar 1992, 15(3):190-196.
32. Strippoli G.F., Navaneethan S.D., Johnson D.W., Perkovic V., Pellegrini F., Nicolucci A., et al. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ Mar 22 2008, 336(7645):645-651.
33. Coresh J., Longenecker J.C., Miller E.R., Young H.J., Klag M.J. Epidemiology of cardiovascular risk factors in chronic renal disease. J Am Soc Nephrol Dec 1998, 9(Suppl. 12):S24-S30.
34. Houslay E.S., Sarma J., Uren N.G. The effect of intensive lipid lowering on coronary atheroma and clinical outcome. Heart Feb 2007, 93(2):149-151.
35. Schmermund A., Achenbach S., Budde T., Buziashvili Y., Forster A., Friedrich G., et al. Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial. Circulation Jan 24 2006, 113(3):427-437.
36. Chertow G.M., Burke S.K., Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int Jul 2002, 62(1):245-252.
37. Raggi P., Chertow G.M., Torres P.U., Csiky B., Naso A., Nossuli K., et al. The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant Apr 2011, 26(4):1327-1339.
38. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., et al. Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol Apr 14 2009, 53(15):e1-e90.